MedX Health Corp
MedX Health Corp, a leading innovator in the healthcare technology sector, is headquartered in Canada and operates extensively across North America. Founded in 2006, the company has made significant strides in the field of telemedicine and dermatology, focusing on advanced skin imaging and diagnostic solutions. MedX Health is renowned for its proprietary products, including the DermSecure platform, which leverages artificial intelligence to enhance skin cancer detection and patient care. This unique approach not only streamlines the diagnostic process but also empowers healthcare professionals with precise tools for early intervention. With a strong market position, MedX Health has garnered recognition for its commitment to improving patient outcomes and has established itself as a trusted partner in the healthcare community. The company continues to push the boundaries of medical technology, ensuring that quality care is accessible to all.
DitchCarbon Score
How does MedX Health Corp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MedX Health Corp's score of 41 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MedX Health Corp's reported carbon emissions
In 2023, MedX Health Corp reported total carbon emissions of approximately 9,000,000 kg CO2e, comprising 4,381,000 kg CO2e from Scope 1, 1,214,000 kg CO2e from Scope 2, and 4,002,000 kg CO2e from Scope 3 emissions. The previous year, 2022, saw total emissions of about 10,800,000 kg CO2e, with Scope 1 emissions at 5,408,000 kg CO2e, Scope 2 at 1,545,000 kg CO2e, and Scope 3 at 3,403,000 kg CO2e. In 2024, emissions slightly decreased to approximately 10,000,000 kg CO2e, with Scope 1 emissions at 4,351,000 kg CO2e, Scope 2 at 5,880,000 kg CO2e, and Scope 3 at 5,355,000 kg CO2e. Despite these figures, MedX Health Corp has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company continues to monitor and report its emissions across all three scopes, reflecting a commitment to transparency in its climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 5,408,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,545,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 3,403,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MedX Health Corp is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
